Anti-CMV monoclonal antibody
Latest Information Update: 24 Oct 2021
At a glance
- Originator Scotgen [CEASED]
- Class Antivirals; Monoclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cytomegalovirus infections
Most Recent Events
- 31 Dec 1995 Discontinued-Preclinical for Cytomegalovirus infections in United Kingdom (Unknown route)
- 02 Nov 1994 Preclinical development for Cytomegalovirus infections in United Kingdom (Unknown route)